Amendment No. 3 to the Multi-Product License Agreement, dated August 26, 2016, by and between the registrant and Lonza Sales AG

EX-10.1 2 omed-ex101_189.htm EX-10.1 - AMENDMENT 3 LONZA omed-ex101_189.htm

Exhibit 10.1

 

 

CONFIDENTIALLONZA

 

 

 

 

AMENDMENT NO.3

to the

Multi-Product License Agreement

dated 22 August 2012

between

LONZA SALES AG

and

ONCOMED PHARMACEUTICALS, INC

 

 

 

 

CONFIDENTIALLONZA

 

THIS AMENDMENT is made the 26 day of August 2016

BETWEEN

LONZA SALES AG incorporated and registered in Switzerland whose registered office is at Muenchensteinerstrasse 38, CH-4002, Basel, Switzerland (hereinafter referred to as "Lonza") and

ONCOMED PHARMACEUTICALS, INC., incorporated in Delaware whose office is at 800 Chesapeake Drive, Redwood City, CA 94063, USA (hereinafter referred to as "OncoMed")

WHEREAS

A.

OncoMed and Lonza entered into a Multi-Product License Agreement dated 22 August 2012 (hereinafter referred to as the "Agreement"), in respect of the use by OncoMed of Lonza's proprietary System (as defined in the Agreement).

B.

Lonza now wishes to clarify the content of Schedule 2 in the Agreement.

D.

Lonza and OncoMed agree to amend the terms of the Agreement.

NOW THEREFORE in consideration of the mutual promises and covenants contained herein, and other good and valuable consideration the receipt of which is hereby acknowledged, it is hereby agreed by the parties to amend the Agreement as follows:

1.

The words and phrases defined in the Agreement shall have the same meanings in this Amendment.

2.

Schedule 2 of the Agreement is hereby deleted in its entirety and replaced by the Schedule 2 annexed hereto.

3.

Save as herein provided all other terms and conditions of the Agreement shall remain in full force and effect.


 

 

 

CONFIDENTIALLONZA

 

 

IN WITNESS WHEREOF the parties have caused this Amendment No. 3 to be executed by their respective representatives thereunto duly authorized as of the day and year first above written.

Signed for and on behalf of/S/ Marie Leblanc

LONZA SALES AG

Marie Leblanc

Director Strategic Marketing

 

TITLE

Signed for and on behalf of/S/Cordula Altekrüger

LONZA SALES AG

Cordula Altekrüger

Senior Legal Counsel

 

TITLE

Signed for and on behalf of/S/ John Lewicki

ONCOMED PHARMACEUTICALS, INC.

EVP, CSO

 

TITLE

 

 

 

 

CONFIDENTIALLONZA

 

 

SCHEDULE 2

PRODUCTS

 

 

1.

OMP-21M18

 

2.

OMP-59R5

 

3.

OMP-18R5

 

4.

OMP-54F28

 

5.

OMP-52M51

 

6.

OMP-305B83

 

7.

OMP-131R10

 

8.

OMP-336B11

 

9.

OMP-313M32